[Clinico-immunologic changes in patients with cervical cancer after treatment with thymalin].
The results of a clinical study of a polypeptide preparation of the thymus-thymalin in 50 patients with cervical carcinoma are discussed. Thymalin was found to exert a beneficial effect in various immuno-suppressive states involved in carcinoma of uterine cervix. Since the preparation has a distinct stimulating effect, its administration should be included into different schemes of complex therapy of cervical carcinoma.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000917:Antibody Formation; D001402:B-Lymphocytes / Q000276:immunology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D013601:T-Lymphocytes / Q000276:immunology; D013951:Thymus Hormones / Q000008:administration & dosage*; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000628:therapy
D000276:Adjuvants, Immunologic; D013951:Thymus Hormones; C032805:thymalin
Kliniko-immunologicheskie izmeneniia u bol'nykh rakom sheĭki matki pod vozdeĭstviem timalina.